{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:38Z","timestamp":1707524198725},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,18]]},"DOI":"10.7759\/cureus.12147","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T17:28:52Z","timestamp":1608312532000},"source":"Crossref","is-referenced-by-count":2,"title":["Bilateral Hydronephrosis From Retroperitoneal Fibrosis"],"prefix":"10.7759","author":[{"given":"Radhika","family":"Sheth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Retention renale par periureterite","volume":"9","author":"Albarran J","year":"1905","unstructured":"Albarran J. Retention renale par periureterite. Liberation externe de l\u2019uretere. Assoc Fr Urol. 1905, 9:511-7.","journal-title":"Liberation externe de l\u2019uretere. Assoc Fr Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)69482-5","article-title":"Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process","volume":"59","author":"Ormond JK","year":"1948","unstructured":"Ormond JK. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol. 1948, 59:1072-9. 10.1016\/s0022-5347(17)69482-5","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel EFH","year":"2009","unstructured":"van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse ALHJ. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009, 88:193-201. 10.1097\/MD.0b013e3181afc420","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1599-z","article-title":"Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease","volume":"12","author":"Rossi GM","year":"2017","unstructured":"Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med. 2017, 12:287-99. 10.1007\/s11739-016-1599-z","journal-title":"Intern Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.21698","article-title":"Chronic periaortitis and HLA-DRB1* 03: another clue to an autoimmune origin","volume":"55","author":"Martorana D","year":"2006","unstructured":"Martorana D, Vaglio A, Greco P, et al.. Chronic periaortitis and HLA-DRB1* 03: another clue to an autoimmune origin. Arthritis Rheum. 2006, 55:126-30. 10.1002\/art.21698","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(03)00056-1","article-title":"Evidence of autoimmunity in chronic periaortitis: a prospective study","volume":"114","author":"Vaglio A","year":"2003","unstructured":"Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med. 2003, 114:454-62. 10.1016\/s0002-9343(03)00056-1","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0789-2","article-title":"Chronic periaortitis: an update","volume":"20","author":"Palmisano A","year":"2018","unstructured":"Palmisano A, Maritati F, Vaglio A. Chronic periaortitis: an update. Curr Rheumatol Rep. 2018, 20:80. 10.1007\/s11926-018-0789-2","journal-title":"Curr Rheumatol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh326","article-title":"Chronic periaortitis","volume":"43","author":"Jois RN","year":"2004","unstructured":"Jois RN, Gaffney K, Marshall T, Scott DGI. Chronic periaortitis. Rheumatology. 2004, 43:1441-6. 10.1093\/rheumatology\/keh326","journal-title":"Rheumatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0663","article-title":"Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes","volume":"86","author":"Kermani TA","year":"2011","unstructured":"Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011, 86:297-303. 10.4065\/mcp.2010.0663","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.02.268","article-title":"Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone","volume":"49","author":"van Bommel EFH","year":"2007","unstructured":"van Bommel EFH, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. 2007, 49:615-25. 10.1053\/j.ajkd.2007.02.268","journal-title":"Am J Kidney Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.08.033","article-title":"Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases","volume":"116","author":"Marcolongo R","year":"2004","unstructured":"Marcolongo R, Tavolini IM, Laveder F, et al.. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med. 2004, 116:194-7. 10.1016\/j.amjmed.2003.08.033","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015101110","article-title":"Idiopathic retroperitoneal fibrosis","volume":"27","author":"Vaglio A","year":"2016","unstructured":"Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. 2016, 27:1880-9. 10.1681\/ASN.2015101110","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196602172740701","article-title":"Fibrotic disorders associated with methysergide therapy for headache","volume":"274","author":"Graham JR","year":"1966","unstructured":"Graham JR, Suby HI, LeCompte PR, Sadowsky NL. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med. 1966, 274:359-68. 10.1056\/NEJM196602172740701","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.24461","article-title":"Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?","volume":"61","author":"Magrey MN","year":"2009","unstructured":"Magrey MN, Husni ME, Kushner I, Calabrese LH. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?. Arthritis Rheum. 2009, 61:674-9. 10.1002\/art.24461","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr779","article-title":"Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"27","author":"Pelkmans LG","year":"2012","unstructured":"Pelkmans LG, Aarnoudse A-JLH, Hendriksz TR, van Bommel EFH. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant. 2012, 27:2819-25. 10.1093\/ndt\/gfr779","journal-title":"Nephrol Dial Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.02.008","article-title":"(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"21","author":"Jansen I","year":"2010","unstructured":"Jansen I, Hendriksz TR, Han SH, Huiskes AWLC, van Bommel EFH. (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2010, 21:216-21. 10.1016\/j.ejim.2010.02.008","journal-title":"Eur J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.10.046","article-title":"[18F]-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study","volume":"71","author":"Fernando A","year":"2017","unstructured":"Fernando A, Pattison J, Horsfield C, D\u2019Cruz D, Cook G, O\u2019Brien T. [18F]-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study. Eur Urol. 2017, 71:926-33. 10.1016\/j.eururo.2016.10.046","journal-title":"Eur Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-1-201101040-00005","article-title":"Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series","volume":"154","author":"Scheel PJ","year":"2011","unstructured":"Scheel PJ, Feeley N, Sozio SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med. 2011, 154:31-6. 10.7326\/0003-4819-154-1-201101040-00005","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.4.427","article-title":"Treatment of idiopathic retroperitoneal fibrosis using cyclosporin","volume":"60","author":"Marzano A","year":"2001","unstructured":"Marzano A, Trapani A, Leone N, Actis GC, Rizzetto M. Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis. 2001, 60:427-8. 10.1136\/ard.60.4.427","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.38032","article-title":"Brief report: interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis","volume":"65","author":"Augusto Vaglio","year":"2013","unstructured":"Augusto Vaglio , Maria G Catanoso, Lucia Spaggiari, et al.. Brief report: interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. 2013, 65:2469-2475. 10.1002\/art.38032","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45034-bilateral-hydronephrosis-from-retroperitoneal-fibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:26Z","timestamp":1707506726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45034-bilateral-hydronephrosis-from-retroperitoneal-fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12147","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}